Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence.

Authors: de Pádua Covas Lage, Luís Alberto^1,2 (AUTHOR) fabio.alessandro@alumni.usp.br, De Vita, Rita Novello¹ (AUTHOR), de Oliveira Alves, Lucas Bassolli¹ (AUTHOR), Jacomassi, Mayara D'Auria¹ (AUTHOR), Culler, Hebert Fabrício^1,2 (AUTHOR), Reichert, Cadiele Oliana² (AUTHOR), de Freitas, Fábio Alessandro² (AUTHOR), Rocha, Vanderson^1,2,3,4 (AUTHOR), Siqueira, Sheila Aparecida Coelho⁵ (AUTHOR), de Oliveira Costa, Renata^6,7 (AUTHOR) renatadeoliveiracosta@uol.com.br, Pereira, Juliana^1,2,7 (AUTHOR)

Source: Cancers. Apr2024, Vol. 16 Issue 8, p1459. 22p.

Subject Terms: *SURVIVAL rate, *SCIENTIFIC observation, *TREATMENT effectiveness, *RETROSPECTIVE studies, *AGE distribution, *DESCRIPTIVE statistics, *MEDICAL needs assessment, *COMPARATIVE studies, *B cell lymphoma, *OLD age

CRIPTOCOCOSE PULMONAR EM PACIENTE CANDIDATA À TMO ALOGÊNICO - UM RELATO DE CASO

Authors: Bezerra, Camila Loredana, Menezes, Letícia Mattos, da Cruz, Isabela C.L. Vieira, de Sousa, Alessandra M. Cerqueira, de Vita, Rita Novello, Rocha, Vanderson Geraldo, Costa, Silvia Figueiredo

Source: BRAZILIAN JOURNAL OF INFECTIOUS DISEASES. 26(S2)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100169475919.0x000001&indx=1&recIds=ETOCvdc_100169475919.0x000001

Age ≥ 75 Years, Clinical Stage III/IV, Neutrophilia and High Lymphocyte/Monocyte Ratio Predict Decreased Overall Survival in Elderly Patients with DLBCL, NOS Older Than 70 Years

Authors: Lage, Luis Alberto de Padua Covas ^*, de Vita, Rita Novello ^*, Alves, Lucas Bassolli de Oliveira ^*, Jacomassi, Mayara D'Auria ^*, Culler, Hebert Fabricio ^*, Reichert, Cadiele Oliana ^*, Costa, Renata Oliveira, Coelho de Siqueira, Sheila Aparecida ^*, Rocha, Vanderson ^*, Pereira, Juliana

Source: In Blood 15 November 2022 140 Supplement 1:9533-9535